High expression of FOXP3, CD14, and ARG1 mRNA in the primary tumors of high-risk NB patients was predictive of better survival, suggesting that the immune status of the tumor may influence the natural history of this pediatric cancer. The gene discussed is FOXP3; the disease is childhood malignant neoplasm.